InvestorsHub Logo

jaxstraw

08/17/13 7:45 AM

#2736 RE: James salmon #2735

Just as the accepting of OD for anal cancer was greeted with little fanfare ( in regards too share price) , so would the denial of either of the other two.

There should be no reason not too disclose.